Skip to main content
Premium Trial:

Request an Annual Quote

Private Eyes on Janet Woodcock

Amphastar Pharmaceuticals hired a private detective firm to poke around in the lives of both Janet Woodcock, the director of FDA's Center for Drug Evaluation and Research, and Moheb Nasr, who is in charge of the Office of New Drug Quality Assessment, Politico reports. The company says it wanted to determine whether the officials were favoring its competitor, Momenta. The investigative firm Kroll, Politico reports, came up empty. Amphastar's general counsel, Jason Shandell, says it has the "right to question your government" and that "there was no impropriety here." Still, Senate Finance Committee Chairman Max Baucus (D-Mont.) wasn't pleased. "Pharmaceutical companies should be focusing on getting their drugs approved based on health research and science rather than wasting their resources hiring private investigators to snoop around the lives of FDA regulators and their families," he says.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.